ArticleOncotarget2015

Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acquired resistance to cyclin-dependent kinase inhibitors in leukemia.

Yuh-Ying Yeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.